Join or renew today
This panel offers examples of widely accepted medical practices and treatments that need a second look, including problems with screening for cancer, focusing on the controversy surrounding CT for lung cancer and PSA testing. Topics include the use of surrogate endpoints; how trial design can be manipulated to achieve the desired outcome; the meaning of such terms as underpowered, number needed to treat, sensitivity, specificity, all-cause mortality and relative risk reduction versus absolute risk reduction.
The page you have requested is available to AHCJ members only. If you are
a member, please login below.
If you're not a member, we invite you to join us. Read about member
benefits and how to join.
Please provide your user ID and password below:
~ or ~
Log in by email, using your email address: